Home・Lista de Ações・Codexis Inc

Codexis Inc

Fechado

SetorSaúde

1.47 -25.38

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1.46

Máximo

1.55

Indicadores-chave
By Trading Economics
Rendimento	-18M -8.7M
Vendas	-24M 15M
EPS	-0.1
Margem de lucro	-57.083
Funcionários	146
EBITDA	-23M -6.4M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+395.27% upside

Dividendos
By Acuity
Próximos Ganhos	12 de ago. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-27M 201M
Abertura anterior	26.85
Fecho anterior	1.47

Sentimento de Notícias

By Acuity

30%

70%

76 / 340 Ranking em Healthcare

Codexis Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

24 de jul. de 2026, 19:01 UTC

News

Codexis Inc shares are lower following a public offering of 16.67 million shares at $1.50 each, below Thursday's close of $1.99.

23 de jul. de 2026, 23:51 UTC

News

Codexis Inc announced a public offering of common stock, contributing to a notable decline in shares during after-market trading.

22 de jul. de 2026, 20:01 UTC

Codexis Inc shares are lower during Wednesday's session, continuing a trend of declines since Tuesday's close. The stock remains below its 20-day moving average.

Comparação entre Pares

Variação de preço

Codexis Inc Previsão

Preço-alvo

By TipRanks

395.27% parte superior

Previsão para 12 meses

Média 7.33 USD 395.27%

Máximo 11 USD

Mínimo 2 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Codexis Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

Comprar

Manter

Vender

Com base em 4 analistas que deram avaliações de ações para Codexis Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

76 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.